Infection
Prevalence of preconception TORCH infections and its influential factors: evidence from over 2 million women with fertility desire in southern China
Aug
Neu N, Duchon J, Zachariah P. TORCH infections. Clin Perinatol. 2015;42:77–103.
Google Scholar
Megli CJ, Coyne CB. Infections at the maternal–fetal interface: an overview of pathogenesis and defence. Nat Rev Microbiol. 2022;20:67–82.
Google Scholar
Arora N, Sadovsky Y, Dermody TS, Coyne CB. Microbial Vertical transmission during human pregnancy. Cell Host Microbe. 2017;21:561–7.
Google Scholar
Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 2013;91:501–8.
Google Scholar
Rubella vaccines: WHO position paper – July. 2020. https://www.who.int/publications-detail-redirect/WHO-WER9527. Accessed 30 Sep 2022.
Winter AK, Moss WJ, Rubella. The Lancet. 2022;399:1336–46.
Miller E, Cradock-Watson JohnE, Pollock Thomas M. Consequences of confirmed maternal rubella at successive stages of pregnancy. The Lancet. 1982;320:781–4.
Leruez-Ville M, Sellier Y, Salomon LJ, Stirnemann JJ, Jacquemard F, Ville Y. Prediction of fetal infection in cases with cytomegalovirus immunoglobulin M in the first trimester of pregnancy: a retrospective cohort. Clin Infect Dis. 2013;56:1428–35.
Google Scholar
Kilby MD, Ville Y, Acharya G. Screening for cytomegalovirus infection in pregnancy. BMJ. 2019;:l6507.
Zhang S, Hu L, Chen J, Xu B, Zhou Y-H, Hu Y. Cytomegalovirus seroprevalence in pregnant women and association with adverse Pregnancy/Neonatal outcomes in Jiangsu Province, China. PLoS ONE. 2014;9:e107645.
Google Scholar
Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009;39:1385–94.
Google Scholar
Wang S, Wang T, Zhang W, Liu X, Wang X, Wang H, et al. Cohort study on maternal cytomegalovirus seroprevalence and prevalence and clinical manifestations of congenital infection in China. Medicine. 2017;96:e6007.
Google Scholar
Zuhair M, Smit GSA, Wallis G, Jabbar F, Smith C, Devleesschauwer B, et al. Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis. Rev Med Virol. 2019;29:e2034.
Google Scholar
Zhou Q, Wang Q, Shen H, Zhang Y, Zhang S, Li X, et al. Seroepidemiological map of Toxoplasma gondii infection and associated risk factors in preconception period in China: a nationwide cross-sectional study. J Obstet Gynaecol Res. 2018;44:1134–9.
Google Scholar
Zhou Q, Wang Q, Shen H, Zhang Y, Zhang S, Li X, et al. Seroprevalence of Cytomegalovirus and Associated factors among Preconception Women: a cross-sectional Nationwide Study in China. Front Public Health. 2021;9:631411.
Google Scholar
Zhou Q, Wang Q, Shen H, Zhang Y, Zhang S, Li X, et al. Rubella virus immunization status in preconception period among chinese women of reproductive age: a nation-wide, cross-sectional study. Vaccine. 2017;35:3076–81.
Google Scholar
Qin X, Zhang S, Liu H, Cheng G, Liu Y, Hu M, et al. Seroepidemiology of TORCH infections among 1.7 million women of Childbearing Age in Rural China: a Population-Based cross-sectional study. Am J Trop Med Hyg. 2021;105:1202–9.
Google Scholar
Chimhuya S, Manangazira P, Mukaratirwa A, Nziramasanga P, Berejena C, Shonhai A, et al. Trends of rubella incidence during a 5-year period of case based surveillance in Zimbabwe. BMC Public Health. 2015;15:294.
Google Scholar
Mhandire D, Rowland-Jones S, Mhandire K, Kaba M, Dandara C. Epidemiology of Cytomegalovirus among pregnant women in Africa. J Infect Dev Ctries. 2019;13:865–76.
Google Scholar
Jiang R-L, Ma L-H, Ma Z-R, Hou G, Zhao Q, Wu X. Seroprevalence and associated risk factors of Toxoplasma gondii among Manchu pregnant women in northeastern China. Microb Pathog. 2018;123:398–401.
Google Scholar
Jones JL. Toxoplasma gondii infection in the United States: Seroprevalence and Risk factors. Am J Epidemiol. 2001;154:357–65.
Google Scholar
Avelino MM, Campos Júnior D, de Parada JB, de Castro AM. Risk factors for Toxoplasma gondii infection in women of childbearing age. Braz J Infect Dis. 2004;8.
Gelaye W, Kebede T, Hailu A. High prevalence of anti-toxoplasma antibodies and absence of Toxoplasma gondii infection risk factors among pregnant women attending routine antenatal care in two hospitals of Addis Ababa, Ethiopia. Int J Infect Dis. 2015;34:41–5.
Google Scholar
Guangdong Provincial Statistical Information Network. Guangdong Statistical Yearbook 2015-20. http://stats.gd.gov.cn/gdtjnj/index.html. Accessed 25 Dec 2022.
Zhang S, Wang Q, Shen H. Design of the National Free Preconception Health Examination Project in China. Zhonghua Yi Xue Za Zhi. 2015;:162–5.
Wang Q, Zhang M, Zhang S, Hu M, Liu N, Kang X. Establishment of quality assurance system of the National Free Preconception Health Examination Project in China. Zhonghua Yi Xue Za Zhi. 2015;:166–8.
Jones JL, Kruszon-Moran D, Elder S, Rivera HN, Press C, Montoya JG, et al. Toxoplasma gondii infection in the United States, 2011–2014. Am J Trop Med Hyg. 2018;98:551–7.
Google Scholar
Fuchs FE, Pauly M, Black AP, Hübschen JM. Seroprevalence of ToRCH Pathogens in Southeast Asia. Microorganisms. 2021;9:574.
Google Scholar
Gebremedhin EZ, Abebe AH, Tessema TS, Tullu KD, Medhin G, Vitale M, et al. Seroepidemiology of Toxoplasma gondii infection in women of child-bearing age in central Ethiopia. BMC Infect Dis. 2013;13:101.
Google Scholar
Lv F, Xie D, Chen M. Analyzed the TORCH screening of free pre-pregnancy health examination of 210 000 people in Guangxi. Chin J Birth Health Heredity. 2014;22:80–2.
Feng, Jin Y, Han W. Analysis of the TORCH detection results among 193490 pre-pregnancy women underwent eugenic health check in Liaoning province. China & Foreign Medical Treatment. 2014;33:55–6.
Robinson E, de Valk H, Villena I, Le Strat Y, Tourdjman M. National perinatal survey demonstrates a decreasing seroprevalence of Toxoplasma gondii infection among pregnant women in France, 1995 to 2016: impact for screening policy. Euro Surveill. 2021;26:1900710.
Google Scholar
Cook EAJ, Gitahi N, de Glanville WA, Thomas LF, Kariuki S, Kang’ethe E, et al. Prevalence and risk factors for exposure to Toxoplasma gondii in slaughterhouse workers in western Kenya. BMC Infect Dis. 2021;21:944.
Google Scholar
Antinarelli LMR, Silva MR, Guimarães RJ, de PS, Terror MS, Lima PE, Ishii J, de SC, et al. Rural residence remains a risk factor for Toxoplasma infection among pregnant women in a highly urbanized brazilian area: a robust cross-sectional study. Trans R Soc Trop Med Hyg. 2021;115:896–903.
Google Scholar
Avelar MV, Martinez VO, de Moura DL, Barros IA, Primo AA da, Duarte S et al. AO,. Association between seroprevalence of IgG anti-Toxoplasma gondii and risk factors for infection among pregnant women in Climério de Oliveira Maternity, Salvador, Bahia, Brazil. Rev Inst Med trop S Paulo. 2017;59.
Costa GB, De Oliveira MC, Gadelha SR, Albuquerque GR, Teixeira M, Raiol MR da. Infectious diseases during pregnancy in Brazil: seroprevalence and risk factors. J Infect Dev Ctries. 2018;12:657–65.
Ju D, Li XZ, Shi YF, Li Y, Guo LQ, Zhang Y. Cytomegalovirus shedding in seropositive healthy women of reproductive age in Tianjin, China. Epidemiol Infect 148:e34.
Mussi-Pinhata MM, Yamamoto AY. Natural history of congenital cytomegalovirus infection in highly seropositive populations. J Infect Dis. 2020;221 Supplement1:15–22.
Qi Y, Zhu S, Li C, Wu H, Yue H, Zhang Y, et al. Seroepidemiology of TORCH antibodies in the reproductive-aged women in China. Eur J Obstet Gynecol Reproductive Biology. 2020;254:114–8.
Google Scholar
Jin Q, Su J, Wu S. Cytomegalovirus infection among pregnant women in Beijing: Seroepidemiological Survey and Intrauterine Transmissions. J Microbiol Biotechnol. 2017;27:1005–9.
Google Scholar
Meng J, Qin G, Wei Y. Epidemiological analysis on outbreak of Rubella in Middle School in Remote Minority Area. J Med Pest Control. 2010;26:314–6.
Jing W, Yuan Y, Liu M, Ye H, Kong C, Liu J, et al. Ethnic disparities in Hepatitis B virus infection among 1 million Reproductive-Age couples preparing for pregnancy in the rural Yunnan, China: a Population-Based cross-sectional study. Front Med (Lausanne). 2022;8:799873.
Google Scholar
Lanzieri TM, Kruszon-Moran D, Gambhir M, Bialek SR. Influence of parity and sexual history on cytomegalovirus seroprevalence among women aged 20–49 years in the USA. Int J Gynaecol Obstet. 2016;135:82–5.
Google Scholar
Meng Q, Luo J, Li L, Shi W, Yu J, Shen Y, et al. Rubella seroprevalence among pregnant women in Beijing, China. BMC Infect Dis. 2018;18:130.
Google Scholar
Su Q, Feng Z, Hao L, Ma C, Hagan JE, Grant GB, et al. Assessing the burden of congenital rubella syndrome in China and evaluating mitigation strategies: a metapopulation modelling study. Lancet Infect Dis. 2021;21:1004–13.
Google Scholar
Albrecht M, Arck PC. Vertically transferred immunity in neonates: mothers, mechanisms and mediators. Front Immunol. 2020;11:555.
Google Scholar
Li Y, Xu D, Zheng Y, Yan H, Li S, Yi S. Analysis of TORCH infection of 301057 women during prepregnant health examination in Hubei. Mod Prev Med. 2019;46:2384–87.
Xu H, Yu J, Wang Q, Liu H, Wu W. Health examination results of pre-pregnancy eugenics of couples of childbearing age in Hainan, 2017–2018. China Trop Med. 2020;20:56–60.
Zhu Z, Cui A, Wang H, Zhang Y, Liu C, Wang C, et al. Emergence and continuous evolution of genotype 1E rubella viruses in China. J Clin Microbiol. 2012;50:353–63.
Google Scholar
Fabiani M, Ferrante G, Minardi V, Giambi C, Riccardo F, Declich S, et al. Comparison of rubella immunization rates in immigrant and italian women of childbearing age: results from the italian behavioral surveillance system PASSI (2011–2015). PLoS ONE. 2017;12:e0178122.
Google Scholar
Dykewicz CA, Kruszon-Moran D, McQuillan GM, Williams WW, Van Loon FP, Cossen C, et al. Rubella seropositivity in the United States, 1988–1994. Clin Infect Dis. 2001;33:1279–86.
Google Scholar
Amina M-D, Oladapo S, Habib S, Adebola O, Bimbo K, Daniel A. Prevalence of rubella IgG antibodies among pregnant women in Zaria, Nigeria. Int Health. 2010;2:156–9.
Google Scholar
Marchi S, Viviani S, Montomoli E, Trombetta CM. Elimination of congenital rubella: a seroprevalence study of pregnant women and women of childbearing age in Italy. Hum Vaccines Immunotherapeutics. 2020;16:895–8.
Google Scholar
Dontigny L, Arsenault M-Y, Martel M-J. Clinical practice obstetrics committee. Rubella in pregnancy. J Obstet Gynaecol Can. 2008;30:152–8.
Google Scholar
